TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

The WHO reports that tuberculosis cases in children are rising globally. Experts say a rise in TB cases in Europe could mean ...

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery. Methods: From 2006 to 2010, patients on anti-TB treatment were ...

He chronicles the medical advances, most notably the arrival of effective anti-tuberculosis drugs in the 1950s, that have tamed the disease in wealthy countries. (Each year, the United States ...

The treatment of TB involves a combination of several antibiotics. These are aimed at reducing the risk of transmission, ...

In an exclusive interview with Rashmi Mabiyan Kaur, Dr. Sandeep Nayar, Principal Director and HOD, Chest and Respiratory ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. Globally, an estimated 10.8 million people ...

Even if US foreign aid cuts are reversed, the damage to global TB control has already been done, says Saw Swee Hock School of ...

More than half the TB patients in India seek private medical care. The current system of treatment of TB is confined to either public hospitals where treatment is given free but in an ambience which ...

Know about top innovations that will be part of the national TB elimination programme, help in screening and treatment.

HaystackAnalytics unveils ‘TB One’ solution to strengthen India's TB control efforts: Our Bureau, Bengaluru Wednesday, March ...